Our portfolio

Early pregnancy complication diagnostic testing

Sera Prognostics, based in Salt Lake City, Utah, is developing innovative diagnostic tests designed for early prediction pregnancy complications such as preterm birth risk.
Website
  • Domain
    Life Sciences
  • Investment type
    Direct equity
  • Status
    Exit
  • Initial investment
    Public
  • Partnered in
    2015
  • Investment lead
    Lynn Eisenhart
  • Headquarters
    USA
  • Program strategy
    Discovery & Translational Sciences

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.